ArticleFood safety (Tokyo, Japan)2025
Digestibility of Natural and Recombinant Allergenic Peanut Proteins in Artificial Gastrointestinal Fluids.
Article in Food safety (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Safety assessments are necessary for genetically modified foods in many countries, including Japan. Stabilities during pepsin, trypsin, or pancreatin digestion are a key criterion for assessing the allergenic potential of newly expressed proteins (NEPs). In digestibility tests, NEPs produced by heterologous expression systems were frequently used. Polyhistidine tags (His-tags) are primarily/often used to purify recombinant proteins. Studies of His-tags' influences remain limited on the susceptibility of a protein to pepsin/trypsin digestion, although His-tags can affect protein folding and stability. In this study, we compared the digestibility of the natural peanut allergenic proteins Ara h 1 and Ara h 2 to the recombinant Ara h 1 protein with N-terminal His-tag and recombinant Ara h 2 protein with C-terminal His-tag, respectively. Peptides after the proteolysis were then analyzed using liquid chromatography-tandem mass spectrometry to determine the proteolytic cleavage sites. Differences were detected in the C-terminal region after pepsin cleavage of the His-tag extension of Ara h 1 and Ara h 2 proteins. No differences were observed in other cleavage sites between the natural and recombinant Ara h 1 and Ara h 2 proteins. The N-terminal region of Ara h 1 and Ara h 2, at which the epitopes recognized by most patients allergic to peanut were located, was equally resistant to pepsin digestion regardless of the natural or recombinant forms. In this study, an unintended short protein isoform was detected in the recombinant Ara h 2 samples. This short recombinant isoform may be misfolded, and it showed reduced susceptibility to pepsin digestion relative to natural full-length Ara h 2. In this short Ara h 2 isoform, newly paired disulfide bonds may make it more rigid. Recombinant proteins with His-tags can provide nearly comparable results to the corresponding natural proteins in protease digestions and thus offer information useful for safety assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.